Home » Topics » Regulatory

Regulatory
RSS

New formulations of RenaGel approved for use by FDA

July 17, 2000

FDA advisory committee recommends against approval of OTC Mevacor

July 17, 2000

Aventis discovers utility of riluzole in hearing disorders

July 14, 2000

Arthritis Advisory Committee recommends new approval for Remicade

July 13, 2000

Shortened Taxol regimen approved by FDA for advanced ovarian cancer

July 11, 2000

Tamoxifen for DCIS granted FDA approval

July 10, 2000

FDA approves Sarafem for treatment of premenstrual dysphoric disorder

July 7, 2000

Ibandronate reported useful for improving outcome following endoprosthetic implant

July 6, 2000

New combination HCV therapy launched in Germany

July 6, 2000

Sibutramine demonstrates efficacy in urinary incontinence

July 5, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....